beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis

beta-interferon treatment does not immediately slow the progression of axonal injury in multiple sclerosis

書目詳細資料
Main Authors:	Parry, A, Corkill, R, Blamire, A, Palace, J, Narayanan, S, Arnold, D, Styles, P, Matthews, P
格式:	Journal article
出版:	2002

相似書籍

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
由: Parry, A, et al.
出版: (2003)

Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis.
由: Lee, M, et al.
出版: (2000)

Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis.
由: Reddy, H, et al.
出版: (2000)

Axonal damage in the spinal cord of multiple sclerosis patients detected by magnetic resonance spectroscopy.
由: Blamire, A, et al.
出版: (2007)

Use of Anti-Interferon Beta Antibody Measurements in Multiple Sclerosis
由: Sørensen, P, et al.
出版: (2010)

Interferon beta treatment of multiple sclerosis.
由: Markovitz, D
出版: (1994)

Axonal loss in the optic nerve and tract in multiple sclerosis
由: Esiri, M, et al.
出版: (2000)

Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability.
由: De Stefano, N, et al.
出版: (2002)

INTERFERON-BETA TREATMENT OF MULTIPLE-SCLEROSIS - REPLY
由: Sibley, W, et al.
出版: (1994)

Protein co-expression with axonal injury in multiple sclerosis plaques.
由: Diaz-Sanchez, M, et al.
出版: (2006)

Treatment of multiple sclerosis with interferon beta-1 b.
由: Abdul-Ahad, A, et al.
出版: (1997)

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis.
由: Evangelou, N, et al.
出版: (2000)

Axonal injury in reverse.
由: Craner, M, et al.
出版: (2011)

Treatment of multiple sclerosis with interferon beta-1b - Reply
由: Sibley, W, et al.
出版: (1997)

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
由: Clerico, M, et al.
出版: (2008)

Recombinant interferon beta or glatiramer acetate for delaying conversion of the first demyelinating event to multiple sclerosis.
由: Clerico, M, et al.
出版: (2008)

Relating neocortical pathology to disability progression in multiple sclerosis using MRI.
由: Chen, J, et al.
出版: (2004)

Axonal injury in cerebral malaria.
由: Medana, I, et al.
出版: (2002)

The evidence for primary axonal loss in multiple sclerosis
由: Anthony, D, et al.
出版: (2000)

[The evidence for primary axonal loss in multiple sclerosis]
由: Anthony, D, et al.
出版: (2000)

Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis.
由: Evangelou, N, et al.
出版: (2000)

Axon damage and repair in multiple sclerosis.
由: Perry, V, et al.
出版: (1999)

Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patients.
由: Lampasona, V, et al.
出版: (2003)

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis
由: Ebers, G, et al.
出版: (1997)

Axonal buckling following stretch injury
由: Lang, G, et al.
出版: (2017)

Functional brain reorganization for hand movement in patients with multiple sclerosis: defining distinct effects of injury and disability.
由: Reddy, H, et al.
出版: (2002)

Functional brain reorganization for hand movement in patients with multiple sclerosis: Defining distinct effects of injury and disability
由: Reddy, H, et al.
出版: (2002)

The contribution of demyelination to axonal loss in multiple sclerosis
由: DeLuca, G, et al.
出版: (2006)

The contribution of demyelination to axonal loss in multiple sclerosis.
由: DeLuca, G, et al.
出版: (2006)

Randomized controlled trial of interferon-beta-1a in secondary progressive MS - Clinical results
由: King, J, et al.
出版: (2001)

Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
由: Ebers, G, et al.
出版: (1998)

Altered cellular metabolism following traumatic brain injury: a magnetic resonance spectroscopy study.
由: Garnett, MR, et al.
出版: (2001)

Abnormal cerebral blood volume in regions of contused and normal appearing brain following traumatic brain injury using perfusion magnetic resonance imaging.
由: Garnett, MR, et al.
出版: (2001)

Modifying disability in progressive multiple sclerosis.
由: Palace, J, et al.
出版: (2014)

Modifying disability in progressive multiple sclerosis
由: Palace, J, et al.
出版: (2014)

Interferons in relapsing remitting multiple sclerosis.
由: Goodin, D
出版: (2003)

Systemic interferon alfa in multiple sclerosis.
由: Weinshenker, BG, et al.
出版: (1989)

INTERFERON BETA-1B IN THE TREATMENT OF MULTIPLE-SCLEROSIS - FINAL OUTCOME OF THE RANDOMIZED CONTROLLED TRIAL
由: Duquette, P, et al.
出版: (1995)

Discordant white matter N-acetylasparate and diffusion MRI measures suggest that chronic metabolic dysfunction contributes to axonal pathology in multiple sclerosis.
由: Cader, S, et al.
出版: (2007)

Treatment for delaying conversion of the first demyelinating event to multiple sclerosis: a Cochrane review on use of recombinant interferon beta or glatiramer acetate
由: Clerico, M, et al.
出版: (2005)